======= FRMPD4 =======
== Gene Information ==
* **Official Symbol**: FRMPD4
* **Official Name**: FERM and PDZ domain containing 4
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9758|9758]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q14CM0|Q14CM0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=FRMPD4&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FRMPD4|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/300838|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a multi-domain (WW, PDZ, FERM) containing protein. Through its interaction with other proteins (such as PSD-95), it functions as a positive regulator of dendritic spine morphogenesis and density, and is required for the maintenance of excitatory synaptic transmission. [provided by RefSeq, Jan 2010]. COMPLETENESS: complete on the 3' end.
* **UniProt Summary**: Positive regulator of dendritic spine morphogenesis and density. Required for the maintenance of excitatory synaptic transmission. Binds phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:19118189}.
|FERM M|
|PDZ|
|positive regulation of synapse structural plasticity|
|regulation of synapse structural plasticity|
|postsynaptic actin cytoskeleton organization|
|postsynaptic cytoskeleton organization|
|phosphatidylinositol-4,5-bisphosphate binding|
|postsynapse organization|
|dendritic spine|
|regulation of synapse organization|
|regulation of synapse structure or activity|
|postsynaptic density|
|synapse organization|
|glutamatergic synapse|
|cytoskeleton|
|actin cytoskeleton organization|
|actin filament-based process|
|protein-containing complex|
|cytoskeleton organization|
|positive regulation of cellular component organization|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-2.43|
|[[:results:exp406|Thalidomide 20μM R07 exp406]]|-1.75|
|[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.71|
|[[:results:exp493|IL-3 9ng/ml R08 exp493]]|1.95|
|[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|2.31|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/694
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/26|
|bone|0/26|
|breast|0/30|
|central nervous system|0/49|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/11|
|fibroblast|0/1|
|gastric|0/14|
|kidney|0/18|
|liver|0/19|
|lung|0/72|
|lymphocyte|0/16|
|ovary|0/25|
|pancreas|0/22|
|peripheral nervous system|0/15|
|plasma cell|0/12|
|prostate|0/1|
|skin|0/20|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/28|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 17004
* **Expression level (log2 read counts)**: -1.19
{{:chemogenomics:nalm6 dist.png?nolink |}}